The Strengths and Limitations of ICP-MS Analysis
Inductively coupled plasma mass spectrometry (ICP-MS) is a flexible chemical analysis method that can be tailored to meet the demands of a wide variety of industries. In this article, we explore how it works, what it tells us, it's strengths and limitations and how it compares to other techniques in this analytical space.
Unpacking the USDA’s Hemp Testing Framework
Why does hemp have to be reported on a dry-weight basis? What are the essential hemp testing procedures? Analytical Cannabis discusses the details of the USDA's hemp testing framework.
Cannabis Resin and Flower Are Much More Potent Than Fifty Years Ago, Study Finds
THC levels in resins have risen by nearly 25 percent over the past 50 years, according to researchers.
New Colorado Regulations for the Measurement of Heavy Metals in Cannabis Vaping Aerosols, A Realistic and Practical Assessment: Part 1
This three-part series will take a closer look at the real-world, practical assessment of Colorado’s intent to implement these new regulations and their implications for other states that will inevitably follow suit.
The Importance of Mass Spectrometry in Cannabis Testing
With the cannabis industry’s increasing acceptance and regulation, mass spectrometry has also become a technique near-indispensable to the analytical scientists working within the cannabis testing sector.
The Future of Cannabinoid Production and the Battle Royale of Cannabis
Provided by the Eighth Revolution team, the Cannabinoid Corner looks to provide a broader understanding of the entire cannabinoid industry as they see it.
Determining Decarboxylation in the Cannabis Lab
Analytical Cannabis traces the origins of THC and CBD back to cannabigerolic acid (CBGA) and the reactions that change it.
Why Automation is Foundational to the Maturing of the Cannabis Essential Oil Industry
Automation ensures quality, repeatability, and maximum output in lab testing and oil extraction, writes Mike Severino, sales manager at Festo.
Inside the ACI’s CBD Safety Trial
The Association for the Cannabinoid Industry's (ACI) own Paul Duffy tells Analytical Cannabis why it's crucial CBD companies have their toxicology data ready for next March, and how the ACI's own safety trial can help that happen.
